Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Squamous Intraepithelial Lesions 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Sarcoma, Kaposi 1Sarcoma 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Precancerous Conditions 1Pneumonia 1Papilloma 1Pain 1Neutropenia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypokalemia 1Hypertension 1

Interventions

liposomal doxorubicin 2Thalidomide 2Semaxinib 2Paclitaxel 2Filgrastim 2Etoposide 2Docetaxel 2valspodar 1halofuginone 1etoposide phosphate 1entinostat 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1Ritonavir 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Histological Techniques 1Gemcitabine 1Daunorubicin 1Cidofovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × AIDS-related Kaposi sarcoma × Cidofovir × Clear all
NCT00019240 2013-06-20

Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection

National Cancer Institute (NCI)

Phase 2 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡